• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸部壁层和肋骨照射以及接受射波刀立体定向体部放射治疗的早期肺癌患者的毒性反应

Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.

作者信息

Podder Tarun, Biswas Tithi, Yao Min, Zhang Yuxia, Kim Ellen, Ellis Rodney J, Lo Simon S, Machtay Mitchell

机构信息

Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, 11100 Euclid Avenue, LTR B181, Cleveland, OH 44106, USA.

出版信息

Future Oncol. 2014 Dec;10(15):2311-7. doi: 10.2217/fon.14.158.

DOI:10.2217/fon.14.158
PMID:25525841
Abstract

AIM

The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.

MATERIALS & METHODS: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm(3) of chest wall and 1-10 cm(3) of ribs.

RESULTS

Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm(3) of chest wall and 50.4 Gy to 1 cm(3) of rib. Nine patients had more than 30 Gy dose to 30 cm(3) of chest wall. No rib bone fracture was found.

CONCLUSION

No correlations of chest wall pain and volume of irradiation were found.

摘要

目的

本研究旨在评估接受基于射波刀的立体定向体部放射治疗的原发性肺癌患者的胸壁和肋骨毒性。

材料与方法

在本研究中,收集了118例患者的数据,其中25例随访时间较长(平均:21.9个月)的患者被纳入研究。研究参数包括最大点剂量、胸壁1 - 100 cm³和肋骨1 - 10 cm³的剂量。

结果

3例患者出现胸壁疼痛(I级)。25例研究患者胸壁30 cm³平均接受27.7 Gy照射,肋骨1 cm³平均接受50.4 Gy照射。9例患者胸壁30 cm³接受的剂量超过30 Gy。未发现肋骨骨折。

结论

未发现胸壁疼痛与照射体积之间存在相关性。

相似文献

1
Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.胸部壁层和肋骨照射以及接受射波刀立体定向体部放射治疗的早期肺癌患者的毒性反应
Future Oncol. 2014 Dec;10(15):2311-7. doi: 10.2217/fon.14.158.
2
Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.使用实时肿瘤追踪技术对肺肿瘤进行立体定向消融放疗后胸壁毒性的预测因素。
Radiat Oncol. 2017 Apr 5;12(1):66. doi: 10.1186/s13014-017-0803-2.
3
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.胸部接受 >30 Gy 剂量的体积预测了肺癌立体定向体放射治疗后出现严重疼痛和/或肋骨骨折的风险。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):796-801. doi: 10.1016/j.ijrobp.2009.02.027. Epub 2009 May 8.
4
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.风险适应立体定向放疗治疗早期肺癌后胸壁毒性的发生率及危险因素。
J Thorac Oncol. 2011 Dec;6(12):2052-7. doi: 10.1097/JTO.0b013e3182307e74.
5
Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.立体定向体部放射治疗肺癌患者中剂量及氟代脱氧葡萄糖正电子发射断层扫描摄取值与临床胸壁并发症相关性的定量评估
J Xray Sci Technol. 2015;23(6):727-36. doi: 10.3233/XST-150523.
6
Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.对于周围型肺肿瘤患者,在立体定向体部放射治疗中给予9至7次分割的总剂量54 - 56 Gy后发生的放射性肋骨骨折:最大剂量和分割剂量大小的影响
Radiat Oncol. 2015 Apr 22;10:99. doi: 10.1186/s13014-015-0406-8.
7
Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.肺立体定向消融放疗后胸壁毒性的预测因素
Clin Oncol (R Coll Radiol). 2016 Jan;28(1):28-35. doi: 10.1016/j.clon.2015.06.009. Epub 2015 Jun 28.
8
Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.立体定向体部放疗治疗肺部和肝脏恶性病变后的胸壁毒性。
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):692-7. doi: 10.1016/j.ijrobp.2010.03.020. Epub 2011 Feb 1.
9
Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).从肺部立体定向体部放疗(SBRT)预测胸壁毒性。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):974-80. doi: 10.1016/j.ijrobp.2010.12.002. Epub 2011 Feb 6.
10
Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.预测不同分割方案下的肺癌立体定向体放射治疗中的胸壁疼痛。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):427-34. doi: 10.1016/j.ijrobp.2011.06.1971. Epub 2011 Dec 23.

引用本文的文献

1
Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.通过氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)评估的治疗前和治疗后肿瘤代谢活性作为立体定向体部放射治疗早期非小细胞肺癌肿瘤复发和生存结果的预测指标
Adv Radiat Oncol. 2023 Jul 9;9(1):101313. doi: 10.1016/j.adro.2023.101313. eCollection 2024 Jan.